InvestorsHub Logo

MWM

Followers 1063
Posts 141582
Boards Moderated 14
Alias Born 03/31/2006

MWM

Re: None

Saturday, 06/13/2020 10:59:08 PM

Saturday, June 13, 2020 10:59:08 PM

Post# of 233271
This compassionate use study is Amazing!

from the Mayo Clinic released last night on Severe Covid19 patients with Pneumonia

"Results: Twelve patients were treated with lenzilumab. Clinical improvement was observed in 11 out of 12 (92%), with a median time to discharge of 5 days."

"Conclusions: In high-risk COVID-19 patients with severe pneumonia, GM-CSF neutralization with lenzilumab was safe and associated with improved clinical outcomes, oxygen requirement, and cytokine storm."


https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News